A detailed history of Ae Wealth Management LLC transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Ae Wealth Management LLC holds 103,325 shares of SENS stock, worth $48,562. This represents 0.0% of its overall portfolio holdings.

Number of Shares
103,325
Previous 21,300 385.09%
Holding current value
$48,562
Previous $8,000 350.0%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.32 - $0.49 $26,248 - $40,192
82,025 Added 385.09%
103,325 $36,000
Q2 2024

Aug 12, 2024

BUY
$0.37 - $0.52 $1,221 - $1,716
3,300 Added 18.33%
21,300 $8,000
Q1 2024

May 15, 2024

SELL
$0.5 - $0.73 $4,466 - $6,521
-8,933 Reduced 33.17%
18,000 $9,000
Q4 2023

Feb 14, 2024

BUY
$0.48 - $0.7 $952 - $1,388
1,984 Added 7.95%
26,933 $15,000
Q3 2023

Oct 11, 2023

BUY
$0.5 - $1.05 $1,608 - $3,376
3,216 Added 14.8%
24,949 $14,000
Q2 2023

Jul 10, 2023

BUY
$0.55 - $0.89 $1,417 - $2,294
2,578 Added 13.46%
21,733 $16,000
Q1 2023

Apr 14, 2023

SELL
$0.68 - $1.25 $2,102 - $3,865
-3,092 Reduced 13.9%
19,155 $13,000
Q4 2022

Jan 31, 2023

BUY
$0.96 - $1.34 $2,296 - $3,205
2,392 Added 12.05%
22,247 $22,000
Q3 2022

Oct 25, 2022

BUY
$1.02 - $2.23 $645 - $1,411
633 Added 3.29%
19,855 $26,000
Q2 2022

Aug 03, 2022

BUY
$0.94 - $1.94 $18,068 - $37,290
19,222 New
19,222 $20,000
Q1 2021

Apr 27, 2021

SELL
$0.85 - $5.27 $8,500 - $52,699
-10,000 Closed
0 $0
Q4 2020

Feb 01, 2021

BUY
$0.36 - $0.95 $3,600 - $9,500
10,000 New
10,000 $9,000
Q2 2020

Aug 05, 2020

SELL
$0.39 - $0.69 $4,012 - $7,099
-10,289 Closed
0 $0
Q1 2020

May 07, 2020

SELL
$0.56 - $1.62 $4,318 - $12,491
-7,711 Reduced 42.84%
10,289 $7,000
Q3 2019

Nov 05, 2019

BUY
$0.97 - $1.94 $17,460 - $34,920
18,000 New
18,000 $18,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $219M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Ae Wealth Management LLC Portfolio

Follow Ae Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ae Wealth Management LLC with notifications on news.